BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7662687)

  • 1. Adolescents and Norplant: preliminary findings of side effects.
    Kozlowski KJ; Rickert VI; Hendon A; Davis P
    J Adolesc Health; 1995 May; 16(5):373-8. PubMed ID: 7662687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with side effects and health risks associated with Norplant implant use in adolescents.
    Rosenthal SL; Biro FM; Kollar LM; Hillard PJ; Rauh JL
    Contraception; 1995 Nov; 52(5):283-5. PubMed ID: 8585884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary experience with Norplant in an inner city population.
    Cullins VE; Blumenthal PD; Remsburg RE; Huggins GR
    Contraception; 1993 Feb; 47(2):193-203. PubMed ID: 8449019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with elective Norplant removal in black and white women.
    Opara JU; Ernst FA; Gaskin H; Smith L; Nevels HV
    J Natl Med Assoc; 1997 Apr; 89(4):237-40. PubMed ID: 9145628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the acceptability of Norplant contraceptive in four patient populations.
    Dugoff L; Jones OW; Allen-Davis J; Hurst BS; Schlaff WD
    Contraception; 1995 Jul; 52(1):45-9. PubMed ID: 8521714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and experiences of American women electing for early removal of contraceptive implants.
    Frank ML; Ditmore JR; Ilegbodu AE; Bateman L; Poindexter AN
    Contraception; 1995 Sep; 52(3):159-65. PubMed ID: 7587187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary report of Norplant implant insertions in a large urban family planning program.
    Crosby UD; Schwarz BE; Gluck KL; Heartwell SF
    Contraception; 1993 Oct; 48(4):359-66. PubMed ID: 8222663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A five-year clinical evaluation of Norplant contraceptive subdermal implants in Bangladeshi acceptors.
    Akhter H; Dunson TR; Amatya RN; Begum K; Chowdhury T; Dighe N; Krueger SL; Rahman S
    Contraception; 1993 Jun; 47(6):569-82. PubMed ID: 8334891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual bleeding patterns in Norplant-2 implant users.
    Biswas A; Leong WP; Ratnam SS; Viegas OA
    Contraception; 1996 Aug; 54(2):91-5. PubMed ID: 8842585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contraceptive implant use among inner city teens.
    Glantz S; Schaff E; Campbell-Heider N; Glantz JC; Bartlett M
    J Adolesc Health; 1995 May; 16(5):389-95. PubMed ID: 7662690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irregular bleeding, body mass index and coital frequency in Norplant contraceptive users.
    Pasquale SA; Knuppel RA; Owens AG; Bachmann GA
    Contraception; 1994 Aug; 50(2):109-16. PubMed ID: 7956210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Norplant implants in a New York City clinic population.
    Gerber S; Westhoff C; Lopez M; Gordon L
    Contraception; 1994 Jun; 49(6):557-64. PubMed ID: 8070260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contraceptive outcomes among adolescents prescribed Norplant implants versus oral contraceptives after one year of use.
    Berenson AB; Wiemann CM; Rickerr VI; McCombs SL
    Am J Obstet Gynecol; 1997 Mar; 176(3):586-92. PubMed ID: 9077611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Norplant implants among Thai women in Bangkok.
    Chompootaweep S; Kochagarn E; Sirisumpan S; Tang-usaha J; Theppitaksak B; Dusitsin N
    Contraception; 1996 Jan; 53(1):33-6. PubMed ID: 8631187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Norplant contraceptive implants in the immediate postpartum period: safety and tolerance.
    Phemister DA; Laurent S; Harrison FN
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):175-9. PubMed ID: 7847530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
    Berenson AB; Wiemann CM
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1128-35; discussion 1135-7. PubMed ID: 7726249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levonorgestrel implant use among adolescents.
    Mashburn M
    J Pediatr Health Care; 1994; 8(6):255-60. PubMed ID: 7799199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
    Haugen MM; Evans CB; Kim MH
    J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.